Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease

被引：0
|
作者：
Boban, Ana [1 ]
Robert, Sidonio F., Jr. [2 ]
Dubey, Leonid [3 ]
Vilchevska, Kateryna V. [4 ]
Inati, Adlette [5 ,6 ]
Khayat, Claudia Djambas [7 ]
机构：
[1] Zagreb Univ, Univ Hosp Ctr Zagreb, Dept Internal Med, Sch Med, Zagreb, Croatia
[2] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA USA
[3] Communal Nonprofit Enterprise Western Ukrainian S, Lvov, Ukraine
[4] Natl Specialized Childrens Hosp Okhmatdyt, Kiev, Ukraine
[5] Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Byblos, Lebanon
[6] NINI Hosp, Tripoli, Lebanon
[7] St Joseph Univ, Hotel Dieu France Hosp, Beirut, Lebanon
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate is effective for reducing nosebleeds in children and adults with von Willebrand disease
    Boban, A.
    Sidonio, R. F., Jr.
    Dubey, L.
    Vilchevska, K.
    Inati, A.
    Khayat, C. D.
    [J]. HAEMOPHILIA, 2024, 30 : 20 - 20
  • [2] Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Heavy Menstrual Bleeding in Females with Von Willebrand Disease
    Kiss, Csongor
    Boda, Zoltan
    Khayat, Claudia Djambas
    Dubey, Leonid
    Robert, Sidonio F., Jr.
    [J]. BLOOD, 2023, 142
  • [3] Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
    Sidonio, Robert F., Jr.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Lissitchkov, Toshko
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia
    [J]. BLOOD, 2022, 140 : 8438 - 8439
  • [4] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    [J]. BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
  • [5] Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Timofeeva, Margarita
    Khayat, Claudia Djambas
    Inati, Adlette
    Robert, Sidonio F., Jr.
    [J]. BLOOD, 2023, 142
  • [6] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
    Rugeri, Lucia
    Thomas, Will
    Schirner, Kathrin
    Heyder, Lisa
    Auerswald, Guenter
    [J]. THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
  • [7] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 46 - 47
  • [8] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
    Iorio, Alfonso
    James, Paula
    Ma, Alice
    Srivastava, Alok
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
  • [9] Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease
    Khayat, Claudia Djambas
    Robert, Sidonio F., Jr.
    Pavlova, Anna
    [J]. BLOOD, 2023, 142
  • [10] Accumulation of factor VIII and von Willebrand factor during prophylaxis with a plasma-derived von Willebrand FACTOR/FACTOR VIII concentrate during the WIL-31 study
    Kateryna, V. V.
    Vdovin, V.
    Timofeeva, M. A.
    Khayat, C. D.
    Inati, A.
    Sidonio, R. F., Jr.
    [J]. HAEMOPHILIA, 2024, 30 : 139 - 140
12345